Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aminodiphenylmethane SCHEMBL9499747 | 0.95 | ALDH1A1 (0.56) | ALDH1A1TSHRDPP4F2ADRA2A | |
| Styrene SCHEMBL7656757 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TSHRDPP4F2ADRA2A | |
| Hydrochloric Acid SCHEMBL5493381 | 0.83 | ALDH1A1 (0.43) | ALDH1A1TSHRDPP4F2ADRA2A | |
| Aminodiphenylmethane SCHEMBL7897875 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TSHRDPP4F2ADRA2A | |
| Styrene SCHEMBL11034121 | 0.81 | ALDH1A1 (0.70) | ALDH1A1TSHRADRA2AADRA2CLMNA | |
| Aminodiphenylmethane SCHEMBL11059631 | 0.81 | DPP4 (0.48) | ALDH1A1DPP4F2ADRA2AADRA2C | |
| Styrene SCHEMBL21485240 | 0.80 | ALDH1A1 (0.88) | ALDH1A1TSHRLMNA | |
| Styrene SCHEMBL10892600 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNA | |
| Styrene SCHEMBL4986035 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNA | |
| Styrene SCHEMBL11144289 | 0.80 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758250-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-02-19 | — | — | EP | claimed |
| US-5594136-A | USEFUL IN THE SEPARATION OF NEUTRAL AND ANIONIC SPECIES, PHOSPHATE ESTER HYDROLYSIS, MAGNETIC RESONANCE IMAGING AND PHOTODYNAMIC THERAPY | PHARMACYCLICS, INC. (US) | 1997-01-14 | — | — | US | claimed |
| WO-1995029702-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-11-09 | — | — | WO | claimed |
| JP-59186947-A | — | — | None | — | — | JP | disclosed |
| US-20090298048-A1 | NON-FLUORESCENT, NON-ENZYMATIC, CHEMILUMINESCENT AQUEOUS ASSAY | INTEGRIGEN, INC. (US) | 2009-12-03 | — | — | US | disclosed |
| US-20090208451-A1 | HALOGEN PHOSPHONATE MONOESTERS | INTEGRIGEN, INC. (US) | 2009-08-20 | — | — | US | disclosed |
| US-20070249820-A1 | Activatable Ribozymal Purification Constructs and Methods of Use | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2007-10-25 | — | — | US | disclosed |
| WO-2005067665-A2 | ACTIVATABLE RIBOZYMAL PURIFICATION CONSTRUCTS AND METHODS OF USE | UNIVERSITY OF COLORADO (US) | 2005-07-28 | — | — | WO | disclosed |
| WO-2005037228-A2 | HALOGEN PHOSPHONATE MONOESTERS | INTEGRIGEN, INC. (US) | 2005-04-28 | — | — | WO | disclosed |
| EP-0758250-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-02-19 | — | — | EP | disclosed |
| US-5594136-A | USEFUL IN THE SEPARATION OF NEUTRAL AND ANIONIC SPECIES, PHOSPHATE ESTER HYDROLYSIS, MAGNETIC RESONANCE IMAGING AND PHOTODYNAMIC THERAPY | PHARMACYCLICS, INC. (US) | 1997-01-14 | — | — | US | disclosed |
| WO-1995029702-A1 | TEXAPHYRIN SOLID-SUPPORTS AND DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-11-09 | — | — | WO | disclosed |
| EP-0181236-B1 | LHRH ANALOGUES USEFUL IN STIMULATING ANTI-LHRH ANTIBODIES AND VACCINES CONTAINING SUCH ANALOGUES | PITMAN-MOORE, INC. (US) | 1991-10-09 | — | — | EP | disclosed |
| US-4608251-A | ANTIFERILITY AGENTS | PITMAN-MOORE, INC. (US) | 1986-08-26 | — | — | US | disclosed |
| JP-S59186947-A | NOVEL PEPTIDE | KOWA CO | 1984-10-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090208451-A1 | HALOGEN PHOSPHONATE MONOESTERS | FCGRT, PTMS, DNPEP | ALDH1A1 2586/4885TSHR 217/4885DPP4 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.